TipRanks
Go Ultimate55% OFF

Tanvex Biopharma (TANVF) Income Statement

Tanvex Biopharma Income Statement

Last quarter (Q4 2022), Tanvex Biopharma's total revenue was ―. In Q4, Tanvex Biopharma's net income was $-478.01M. See Tanvex Biopharma’s key income statements, including revenue, expenses, profit, and income.

Income Statement
Income StatementDec 22Dec 21Dec 20Dec 19Dec 18
―――――
$ -19.35M$ 3.55M$ 143.00K$ 0.00$ 0.00
―――――
Depreciation and Amortization―――――
$ -1.30B$ -1.25B$ -1.87B$ -2.04B$ -1.75B
$ -1.61B$ -1.60B$ -2.10B$ -2.33B$ -1.95B
―――――
―――――
$ -1.64B$ -1.54B$ -2.10B$ -2.27B$ -1.89B
Per Share Metrics
Basic EPS―――――
Diluted EPS―――――
Weighted Average Shares Outstanding―――――
Weighted Average Shares Outstanding (Diluted)―――――

Currency in USD

Tanvex Biopharma Earnings and Revenue History

-1.8B-1.2B-600M00 %0.4 %0.8 %1.2 %EarningsProfit Margin2022RevenueEarningsProfit Margin